Novartis AG
NVS.TO
Get informed when a big investor buys or sells
+ FollowMarket Cap$268B
Close$
Share Statistics
| Market cap | $268.00 Billion |
|---|---|
| Enterprise Value | $309.31 Billion |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 30.50% |
|---|---|
| Return on Assets | 10.38% |
| Return on Invested Capital | 19.07% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 5.65 |
| Enterprise Value to EBIT | 18.01 |
| Enterprise Value to Net Income | 24 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 1.18 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 21, 2026
EPS Estimate
$3.08
Average shareholder expectationRevenue Estimate
$20.00 B
Average shareholder expectationNext Earnings Call
Expected Date
October 27, 2026
EPS Estimate
$3.23
Average shareholder expectationRevenue Estimate
$20.81 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Novartis AG
75,267 employees
CEO: Vasant Narasimhan Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segm...